PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 1, 1974JNCI Journal of the National Cancer Institute117 citations

In Vivo Inhibition of Murine Leukemia and Sarcoma Viruses by the Heteropolyanion 5-Tungsto-2-antimoniate2

View Full Paper
CJC JasminJCJean‐Claude ChermannGHGilbert Hervé

Key Points

Key points are not available for this paper at this time.

Abstract

The mineral heteropolyanion 5-tungsto-2-antimoniate (TA) protected mice against Friend- and plasma variant-induced leukemias. When it was given on the day of virus inoculation, we obtained either a complete protective effect with no detectable leukemia or a partial protection indicated by the reduced mean spleen weight (MSW), decrease in virus titers in the plasma and the spleen, and increase of the mean survival time. Mice were immunized against Friend leukemia virus with a simultaneous injection of virus and TA. When TA treatment started at day 3 or 7 after virus inoculation, in 2 of 4 experiments, the MSW was significantly reduced. TA also delayed the appearance of tumors in newborn mice inoculated with Moloney murine sarcoma virus. TA did not induce interferon and had no effect on a grafted leukemia. It had only an antivirus effect and its action did not require direct preliminary contact between virus and product.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Jasmin et al. (1974) studied this question.

synapsesocial.com/papers/6a915c2b9732cc92acd2cefdhttps://doi.org/10.1093/jnci/53.2.469
Ask AI
Helpful
Bookmark
Share
View Full Paper